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Total leukocyte count increases significantly in response to infection, trauma, 
inflammation, and certain diseases. Factors affecting leukocyte count in healthy 
adults include sex, hormonal milieu, genetic inheritance, stress level, diet, nutrition, 
and lifestyle (e.g. tobacco-induced inflammatory changes, chronic psychological 
stress, etc.). To date, numerous studies have reported that high but normal leu-
kocyte counts at baseline predict increased cardiovascular and noncardiovascular 
mortality in older adults. Recent findings suggest that elevated leukocyte count 
within the normal range, but especially neutrophil and monocyte counts, may 
be a harbinger of increased systemic inflammation and subclinical disease. Mo-
reover, elderly people who tend to have high but normal leukocyte counts are at 
greater risk of cancer, cardiovascular disease, type 2 diabetes, some other age-
-related conditions, and they also have increased all-cause mortality. These results 
indicate that strong and reliable inflammatory markers, such as leukocyte count, 
may reflect the rate of ageing and therefore can predict long-term survival in the 
elderly. Remarkably, leukocyte count correlates positively with genuine markers 
of systemic inflammation like C-reactive protein and interleukin 6. Interestingly, 
some authors conclude that leukocyte counts have a stronger prognostic ability 
with regard to total and cardiovascular mortality than total cholesterol or low-
-density lipoproteins. The fact that these inflammatory markers are clinically useful 
predictors of long-term survival in the elderly is quite remarkable as these blood 
parameters are included in routine medical check-ups. Therefore, they can be used 
as simple and reliable morphological indicators of chronic systemic inflammation, 
disease progression, and poor prognosis, especially among individuals who are 
likely to develop age-related conditions. Nevertheless, the pathomechanism that 
links elevated but normal leukocyte counts to increased mortality remains poorly 
understood. This review summarises the most important findings on the links 
between leukocyte count, chronic systemic inflammation, and health outcomes 
in older adults. (Folia Morphol 2018; 77, 2: 171–178)
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INTRODUCTION
Leukocytes (white blood cells [WBCs]) are nucle-
ated and translucent unless stained cells that defend 
the body against foreign invaders and abnormal cells 
and therefore are able to leave the blood and migrate 
to the tissues where they perform various activities 
related to immunity, while other blood cells do not 
leave the vasculature. Morphologically, this nucleus 
may be in one piece or in several lobes or segments. 
Young cells have horseshoe-shaped nuclei that be-
come multilobed as these cells grow older. Based 
on the presence or absence of large cytoplasmatic 
organelles called granules (or vesicles), leukocytes 
are classified into granulocytes (i.e. neutrophils, 
eosinophils, and basophils) and agranulocytes (i.e. 
lymphocytes and monocytes). Most of them have 
a short lifespan (usually a few days), but monocytes 
can survive for several months and some lymphocytes 
can live for many years [9]. Granulocytes have lobed 
nuclei and noticeable cytoplasmic granules, while 
agranulocytes have nuclei that are not lobed and 
contain only sparse, fine granules that are not easily 
viewed under an optic microscope. Of these, granu-
locytes, which are also called polymorphonuclear 
leukocytes (PMNs), and especially neutrophils which 
are the most abundant type of PMNs, are the most 
numerous nucleated cells in the blood, constituting 
around 60–70% of all circulating leukocytes. 
Like erythrocytes, leukocytes are constitutively 
produced throughout adult life from haematopoietic 
stem cells in the red bone marrow; they are released 
into the circulation where they are doing their tasks, 
and then removed from the blood by the liver and 
spleen [9]. Unlike erythrocytes, these large, nucleated, 
and translucent cells fulfil important protective func-
tions. They are often capable of extravasation (diape-
desis) and phagocytosis and are highly specialised to 
defend the body against various pathogens, such as 
bacteria, viruses, fungi, parasitic protozoa, worms, 
and other harmful factors like tumour cells or foreign 
substances. In general, leukocytes are motile and very 
flexible. Most of these cells are found in body tissues, 
as opposed to the bloodstream. Some specific mol-
ecules that are released by damaged, abnormal, and 
dead cells, or by foreign invaders, attract leukocytes 
by chemotaxis to the sites of injury, infection, and 
inflammation.
Although all five types of leukocytes contribute to 
the same general function, each type of these cells 
makes a specific contribution to this aspect of homeo-
dynamics. For example, neutrophils and monocytes 
are capable of the process of phagocytosis of various 
pathogens. While neutrophils are the more abundant 
phagocytic cells which are short-lived, monocytes are 
significantly more efficient as they differentiate into 
macrophages which can perform phagocytosis of 
damaged, abnormal or dead cells and tissues at the 
sites of injury or inflammation [10]. During infectious 
response, neutrophils are produced more rapidly, and 
the immature forms of these cells, called band cells 
(or stab cells), may appear in significantly greater 
numbers in the peripheral blood. Normally, band cells 
constitute less than 10% of the total neutrophils. Dur-
ing inflammatory responses, a multitude of neutro-
phils arrive early at the inflammatory site in order to 
engulf and destroy pathogens using toxic substances 
and releasing enzymes that degrade the foreign sub-
stances or tissue components. These enzymes are 
stored in their richly granulated cytoplasm. After their 
mission is accomplished, these cells enter apoptosis 
(programmed cell death) as these toxic substances 
may have pernicious effects on surrounding cells and 
tissues [10]. Neutrophils may also die by necrosis, 
either secondary to programmed cell death if not 
removed or directly due to general abuse. Eosino-
phils, which usually make up about 1–3% of blood 
leukocytes and are about the same size as neutrophils 
or slightly larger, can detoxify foreign proteins and 
other substances and phagocytise antigen-antibody 
complexes and different allergens, which is especially 
important in allergic reactions and parasitic infec-
tions, e.g. tapeworm infestations. Basophils, whose 
number is usually less than 1% of total leukocytes, are 
about 12–15 μm in diameter and release histamine, 
which acts as a vasodilator, and heparin, which is 
an anticoagulant, during inflammatory or allergic 
reactions. Lymphocytes are about the same size as 
erythrocytes (about 7 μm in diameter) and they usu-
ally constitute around 20–40% of WBCs. The three 
major types of lymphocytes have different functions 
since they produce antibodies (B cells), manage and 
direct the immune response (T cells), and some can 
directly attack pathogens, as well as abnormal or 
infected cells using cytotoxic substances (NK cells). 
Monocytes are the largest leukocytes (around 20 μm 
in diameter) and they normally constitute about 
2–8% of all WBCs. They can leave the vasculature 
during the process of diapedesis and complete their 
development in the tissues, where they become gi-
ant scavenger cells called macrophages. These cells 
173
P.P. Chmielewski, B. Strzelec, Leukocytes as inflammatory markers
play an extremely important role in the maintenance 
and defence of the body. For example, they can vora-
ciously engulf pathogens, dead and abnormal cells, as 
well as other types of debris. Furthermore, they can 
initiate pro-inflammatory responses. Thus, it is clear 
that chronic systemic inflammation and subclinical 
diseases that are associated with an unhealthy diet, 
lifestyle, or generally poor health can manifest them-
selves in elevated leukocyte counts that are within the 
normal range but may signal health problems. Due 
to lack of leukocytosis this would be nonsignificant 
from a clinical point of view, but at the organismal 
and population level such increased levels of inflam-
matory markers can provide important information 
on risks of age-related diseases and premature death.
FACTORS AFFECTING  
LEUKOCYTE COUNT
In healthy adults, leukocyte count depends on 
many different factors such as age, gender, health 
status (e.g. trauma, infections, sepsis, age-related 
diseases, etc.), environmental factors, genetic inher-
itance, stress level, as well as diet and lifestyle, e.g. 
tobacco-induced inflammatory reactions and chronic 
psychological stress [6, 19, 36]. First of all, it changes 
with age. In newborns, it ranges from 15,000 to 
35,000 cells/μL, and then it decreases gradually [9]. In 
adolescents between the ages of 13 and 15 years, it 
ranges from 7,000 to 8,000 cells/μL. In a healthy adult, 
blood contains 4,000–11,000 WBCs/μL, but during in-
fections or other diseases their number increases sig-
nificantly, thereby providing useful information about 
the health status at the organismal and population 
level [9, 31, 37]. For example, many health conditions 
and chronic diseases, such as cardiovascular disease 
(CVD), hypertension, myocardial infarction, cancer, 
type 2 diabetes, metabolic syndrome, chronic renal 
failure, and autoimmune diseases, are accompanied 
by increased systemic inflammation and elevated 
leukocyte counts [1, 3, 5, 13, 17, 18, 24, 27–29, 32, 
37, 43, 46, 49]. Noteworthy, total leukocyte count 
can rise sharply in response to infections (especially 
during sepsis), trauma, unhealthy diet, physiologic 
stress, or even chronic psychological stress [19, 36]. 
Even though numerous studies have shown that 
elevated leukocyte count may be a genuine indica-
tor of chronic systemic inflammation and subclinical 
disease, this indicator is rarely used in this way by the 
medical profession because lack of leukocytosis sug-
gests that in such cases this simple proxy is clinically 
nonsignificant. However, such a conclusion may be 
erroneous. It should be stressed that it is not leukocy-
tosis that attracts researchers’ attention but elevated 
leukocyte counts within the normal range which are 
reliable inflammatory markers and indicators of sub-
clinical disease, even in physically healthy individuals. 
Namely, they are useful markers of chronic systemic 
inflammation and reliable, strong predictors of long-
term survival in the elderly [9, 31, 37]. Also, recent 
findings suggest that neutrophil/lymphocyte ratio is 
especially useful in predicting cardiovascular mortality 
[14, 30] and increased systemic inflammation in some 
types of cancer [14, 47] or poisoning [22]. 
It should be remembered that blood cell composi-
tion undergoes both short- and long-term changes 
that can result from many different factors. Specifi-
cally, total leukocyte count is a rapidly reacting blood 
parameter in which severe alterations may occur 
within hours due to rapid recruitment from vascular 
or bone marrow reserve pools, or even within minutes 
due to changes in endothelial adhesion or transmi-
gration. Therefore, any comparative study should be 
based on averaged data from frequently repeated 
measurements in the same population studied longi-
tudinally for a long time or other more sophisticated 
methods, so as not to use data that are encumbered 
with the short-term effects that can easily interfere 
with the long-term changes in leukocyte counts. 
SYSTEMIC INFLAMMATION AND  
THE OXIDATION-INFLAMMATION  
THEORY OF AGEING
A perennial question of biogerontology is: ‘What 
are the proximate causes of ageing?’ [7, 8]. According 
to the oxidation-inflammation theory of senescence, 
both oxidative damage and inflammation constitute 
the most important proximate mechanisms of age-
ing [12, 15, 38] and some age-related diseases [1, 2, 
35, 39, 43, 44, 46, 48, 50]. This model also includes 
effects of other factors such as pleiotropic genes, im-
paired homeodynamic mechanisms, disrupted com-
munication between the nervous, endocrine, and im-
mune systems, and reduced capacity of the immune 
system that consists in so-called ‘homeostenosis’ [7]. 
Thus, this theory of ageing concentrates on the links 
between metabolism and immunity [38].
Inflammation constitutes part of highly complex 
response to deleterious factors and harmful stimuli 
such as various pathogens, irritants, oxidative dam-
age, and injury. Many authors conclude that the 
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of risk of myocardial infarction. Later on, it was dem-
onstrated that it is also a useful marker of systemic 
inflammation and subclinical disease in healthy older 
adults [37]. This finding, documented in 2007 and 
bolstered since [9, 31], is a fundamental discovery 
about the associations between reliable markers of 
systemic inflammation, such as total leukocyte count, 
and cardiovascular as well as all-cause mortality in 
healthy older individuals of both sexes. However, 
some studies have concluded that elevated leukocyte 
count as a marker of chronic systemic inflammation 
might be a stronger predictor of mortality in older 
women [31].
LEUKOCYTE COUNT AND CVD
Cardiovascular disease is the leading cause of mor-
bidity and mortality worldwide. Several large studies 
have concluded that roughly 80% of CVD is prevent-
able, which means that lifestyle modifications, such as 
eating a healthy and balanced diet, avoiding smoking 
and drinking, exercising regularly, maintaining a low 
body mass index (BMI), reducing psychological stress, 
and monitoring health outcomes, mitigate the modi-
fiable risk factors. Interestingly, several important risk 
factors associated with CVD, such as lack of physical 
activity, cigarette smoking, low level of high-density 
lipoproteins (HDLs), insulin resistance, overweight, 
obesity, and high level of psychological stress, are 
closely related to increased leukocyte count [5, 6, 9, 
17–19, 36, 45, 46].
While young and middle-aged men are at higher 
risk of CVD than women, women’s risk increases 
significantly following menopause. Numerous studies 
have demonstrated that atherosclerosis is the major 
precursor of CVD in both sexes, presumably due to 
an accumulation of oxidised low-density lipoproteins 
(LDLs) in the arterial intima, which develops relatively 
early in ontogeny and causes lesions to the arterial 
wall, though the role of sex hormones and sex differ-
ences in cells involved in the atherosclerotic process 
are not well understood [16]. The oxidised LDLs ex-
ert proatherogenic and proinflammatory effects as 
they activate endothelial cells and macrophages to 
produce adhesion molecules and chemokines that 
attract monocytes and other leukocytes. With ageing, 
the production of proatherogenic and proinflamma-
tory factors, the formation of lesions to the arterial 
wall, and the accumulation of atherosclerotic plaques 
increase significantly, though the atherosclerotic pro-
cess starts to develop at young age and occurs even 
process of inflammageing is one of the hallmarks 
of organismal senescence [38]. In the vasculature, 
lipid peroxidation, injury, and infections are the most 
potent pro-inflammatory factors. The main biological 
function of this process is to combat infection, which 
plays a protective role, but it concurrently contributes 
to the self-destruction of the body in the long run 
[7, 12, 15]. It has been established that chronic sys-
temic inflammation can predispose to various age-re-
lated conditions in the elderly [13], and damage from 
inflammation in these chronic diseases is mediated 
by free radicals and specific inflammatory peptides 
[38]. Thus, inflammation is one of the core processes 
of ageing, and it is involved in both baseline ageing 
[7, 12] and many age-related diseases, including ar-
thritis [50], atherosclerosis [16, 36], CVD [26], insulin 
resistance [17, 45, 46, 48], sarcopaenia and physical 
decline [39, 40], Alzheimer’s disease [20], and cancer 
[4, 11, 13, 18, 28, 33]. Furthermore, both intrinsic 
and extrinsic factors that stimulate inflammation are 
known to be associated with a higher risk of develop-
ing certain types of cancer. For example, recent find-
ings suggest that pro-inflammatory diet (for example, 
cigarette smoking, alcohol consumption, diets that 
have large amounts of red and fried meat but too little 
fresh fruit and vegetables) is related to an increased 
risk of laryngeal and colorectal cancer [41, 42].
Many attempts have been made to determine 
sensitive and specific biomarkers of ageing and strong 
predictors of longevity [8, 9, 31, 37, 38]. In this ap-
proach, reliable markers of oxidative stress and sys-
temic inflammation are of paramount importance. 
With ageing, senescent cells accumulate in the body, 
and they produce pro-inflammatory cytokines, such 
as interleukins (IL): IL-1, IL-2, IL-6, C-reactive protein 
(CRP), and tumour necrosis factor alpha (TNF-a), 
which work with certain cells of the immune system 
such as neutrophils. There are numerous conditions 
that are strongly associated with enhanced systemic 
inflammation, increased oxidative stress, and short-
ened life expectancy. These are, for example, hyper-
tension, obesity, dyslipidaemia, type 2 diabetes, and 
cancer. Interestingly, risk factors of CVD and cancer, 
such as cigarette smoking, low level of physical activ-
ity, and unhealthy diet, which act upon the funda-
mental mechanisms that drive the ageing process at 
its core, are also closely related to a pro-inflammatory 
state and elevated leukocyte counts [8, 9, 31, 37, 38]. 
In the early 1970s, it emerged that leukocyte count 
may be especially valuable in the routine assessment 
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in seemingly healthy individuals who exhibit none of 
the traditional risk factors associated with CVD [34].
The fact that the development of atherosclerosis 
and CVD is accompanied by systemic inflammation 
manifesting itself in frequently elevated total leuko-
cyte count [1] is quite remarkable as this simple blood 
parameter is determined routinely by means of cred-
ible and well-standardised automated methods at 
very low cost and at very high precision in almost any 
routine clinical check-ups [31]. To date, several large 
studies have confirmed that high leukocyte count 
is associated with cardiovascular mortality in both 
sexes and with noncardiovascular mortality in older 
women [1, 5, 18, 21, 26, 27, 31, 35, 43, 44, 47, 49]. 
Nevertheless, the prognostic value of elevated leuko-
cyte count as a marker of inflammatory reactions and 
subclinical disease is not confined to older women as 
the results of some longitudinal studies indicate that 
the association between total leukocyte count and 
long-term survival is more pronounced and perspicu-
ous in older men [9].
LEUKOCYTE COUNT  
AND INSULIN RESISTANCE
Diabetes mellitus is a group of metabolic disorders 
in which hyperglycaemia occurs over a prolonged 
time and results from defects in insulin secretion, 
insulin action, or both. This chronic condition oc-
curs in older adults with increasing frequency with 
each advancing decade and is associated with many 
metabolic complications, long-term damage, as well 
as dysfunction and failure of various organs, includ-
ing the eyes, kidneys, nerves, feet (diabetic foot ul-
cers), heart, and blood vessels. With time, these del-
eterious effects significantly increase mortality and 
morbidity in elderly people. Moreover, this chronic 
condition heightens the risk of other common age-
related disorders. Interestingly, although untreated 
hyperglycaemia leads to increases in mortality and 
CVD, antihyperglycaemic therapies do not alleviate 
this excess burden of disease, which is known as the 
‘diabetic conundrum’.
It has been hypothesised that chronic low-grade 
systemic inflammation is involved in the pathogenesis 
of insulin resistance and type 2 diabetes. The find-
ings of the studies that have examined the patho-
physiological role of an activated immune system and 
chronic systemic inflammation manifesting itself in 
high leukocyte count in the development of type 2 
diabetes in populations with marked insulin resistance 
and relatively high rates of type 2 diabetes, such as 
Pima Indians (i.e. Native Americans living along the 
Gila and Salt Rivers in Arizona who are descendants 
of the ancient Hohokam) have been equivocal as to 
whether increased total leukocyte count is associated 
with insulin resistance and development of type 2 
diabetes. High but normal leukocyte counts have been 
reported to predict type 2 diabetes in Pima Indians, 
even after adjusting for age and gender [46]. Inter-
estingly, this predictive effect of elevated leukocyte 
count persisted even after additional adjustment for 
established predictors of diabetes such as body fat, 
insulin action, and insulin secretory response. After 
adjustment for follow-up duration, increased leuko-
cyte count at baseline turned out to be associated 
with a subsequent worsening of insulin action but 
not insulin secretory response. This study concluded 
that elevated leukocyte count predicts a worsening of 
insulin action and the development of type 2 diabetes 
in Pima Indians [46]. Thus, these findings comport 
with the view that a chronic activation of the immune 
system resulting in chronic low-grade systemic inflam-
mation plays a role in the development of type 2 
diabetes in older adults of both sexes.
To date, numerous studies have shown that high 
total leukocyte count at baseline is associated with 
later development of type 2 diabetes and poor health 
outcomes in older adults [17, 24, 29, 32, 45, 48]. 
Furthermore, many studies have demonstrated that 
higher total leukocyte count is linked to metabolic 
syndrome, but the association between differential 
leukocyte count and this chronic condition is still 
unclear. Similarly, the pathophysiological mechanisms 
that link increase leukocyte count to insulin resist-
ance are not well understood. Many authors have 
come to the conclusion that both leukocyte count 
and insulin resistance depend on an activation of the 
immune system. This sheds some light on tentative 
mechanisms underlying the association between the 
level of inflammatory markers and insulin resistance. 
For example, IL-6 as a pro-inflammatory cytokine that 
is synthesised mainly in the fatty tissue can act as 
a factor influencing both leukocyte differentiation 
and insulin resistance. Interestingly, numerous studies 
have shown that IL-6 can stimulate the inflammatory 
and auto-immune processes in type 2 diabetes as well 
as other disorders such as atherosclerosis, depres-
sion, Alzheimer’s disease, rheumatic arthritis, and 
some types of cancer. Furthermore, some analyses of 
single nucleotide polymorphism of the IL-6 gene have 
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revealed that patients with insulin resistance tend to 
have higher leukocyte counts [24]. Additionally, it 
has been demonstrated that total leukocyte count 
and some other differential counts, such as neutro-
phil, monocyte, and eosinophil counts, depend on 
serum IL-6 level in older women [24, 25]. Thus, it is 
possible that some pro-inflammatory factors that are 
associated with later development of type 2 diabetes 
influence also leukocyte count which is an important 
inflammatory marker.
INFLAMMATORY PATHWAYS,  
NEUROCIRCUITS, AND DEPRESSIVE  
BEHAVIOUR IN OLDER ADULTS 
Interestingly, some investigations have demon-
strated that in women elevated leukocyte counts are 
linked to a faster increase in depressive symptoms 
and both total leukocyte count and associated in-
flammatory markers are closely related to depressive 
symptoms in older adults, but especially in women [3]. 
These findings are consistent with many other studies 
indicating that depression may result from inflamma-
tion as increased systemic inflammation is probably 
a key biological event that heightens the risk of major 
depressive episodes. Furthermore, it has been pro-
posed that the specific interactions between inflam-
matory factors or pathways and neurocircuits in the 
human brain can lead to behavioural responses such 
as alarm and avoidance. In our evolutionary past, these 
behavioural changes were most probably evolutionar-
ily advantageous because they were associated with 
reduced interactions with other individuals, pathogens, 
and predators. Nowadays the same mechanisms and 
interactions seem to drive the development of depres-
sion. Moreover, it has been established that efficacious 
anti-inflammatory therapies can alleviate the burden 
of this perilous mental disorder.
LEUKOCYTE COUNT AS A STRONG  
PREDICTOR OF LONG-TERM  
SURVIVAL IN THE ELDERLY 
The findings of several studies that have reported 
a positive relationship between leukocyte counts and 
mortality in healthy older individuals have stimulated 
further research [23–25]. In 2007, Ruggiero et al. [37] 
demonstrated that elevated but normal leukocyte 
counts are associated with increased mortality from 
both CVD and cancer in older adults from the ‘Balti-
more Longitudinal Study of Aging’. Also, a positive 
relationship between total leukocyte count and BMI 
as well as triglyceride levels was observed in this study, 
while level of physical activity was inversely related to 
leukocyte count. The results of earlier investigations 
suggested that high leukocyte count is linked to insulin 
resistance, type 2 diabetes, and metabolic syndrome. 
In 2014, Nilsson et al. [31] reported further evi-
dence of prognostic significance of total leukocyte 
count with respect to all-cause, cardiovascular, and 
noncardiovascular mortality in a population of indi-
viduals aged 75 years after a follow-up of 10 years. In 
healthy older people, elevated leukocyte count within 
the normal range was linked to increased cardiovas-
cular mortality in both sexes and noncardiovascular 
mortality in women. Subsequent studies not only 
confirmed these observations but also demonstrated 
that the association between total leukocyte count 
and mortality is independent of cigarette smoking 
and is probably not influenced by previous disease his-
tory [21]. Moreover, retrospective longitudinal studies 
of age-dependent changes in total and differential 
leukocyte counts in older men and women studied for 
more than 25 years have shown that longevity favours 
individuals with lower leukocyte counts within the 
normal range, and this relationship was more pro-
nounced and perspicuous in older men, presumably 
due to relatively high risk of cardiovascular mortality 
in the studied population [9]. 
CONCLUSIONS
A multitude of studies have demonstrated that 
elevated leukocyte count at baseline is associated 
with later development of CVD, insulin resistance, 
type 2 diabetes, depressive behaviour, and some oth-
er chronic conditions in the elderly. These findings 
seem compelling as they were obtained in both large 
population-based studies and clinical investigations. 
Although the underlying mechanisms that link high 
leukocyte count to mortality are not well understood, 
many authors have come to the conclusion that an 
activation of the immune system that is accompanied 
by chronic systemic inflammation due to increased 
activity of some pro-inflammatory factors, and espe-
cially IL-6, can explain to some extent these observa-
tions. Since leukocyte count is routinely determined 
at low cost and with high precision, it can serve as 
a simple morphological indicator of increased sys-
temic inflammation, disease progression, and poor 
health outcomes, especially among older adults and 
people who have a greater risk of developing CVD, 
type 2 diabetes, metabolic syndrome, and cancer.
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